This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pankuch, G. A.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pankuch, G. A.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1998, p. 2914-2918, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

In Vitro Selection of Resistance to Four beta -Lactams and Azithromycin in Streptococcus pneumoniae

Glenn A. Pankuch,1 Shane A. Jueneman,1 Todd A. Davies,1 Michael R. Jacobs,2 and Peter C. Appelbaum1,*

Department of Pathology (Clinical Microbiology), Hershey Medical Center, Hershey, Pennsylvania 17033,1 and Department of Pathology (Clinical Microbiology), Case Western Reserve University, Cleveland, Ohio 441062

Received 7 April 1998/Returned for modification 23 July 1998/Accepted 17 August 1998

Selection of resistance to amoxicillin (with or without clavulanate), cefaclor, cefuroxime, and azithromycin among six penicillin G- and azithromycin-susceptible pneumococcal strains and among four strains with intermediate penicillin sensitivities (azithromycin MICs, 0.125 to 4 µg/ml) was studied by performing 50 sequential subcultures in medium with sub-MICs of these antimicrobial agents. For only one of the six penicillin-susceptible strains did subculturing in medium with amoxicillin (with or without clavulanate) lead to an increased MIC, with the MIC rising from 0.008 to 0.125 µg/ml. Five of the six penicillin-susceptible strains showed increased azithromycin MICs (0.5 to >256.0 µg/ml) after 17 to 45 subcultures. Subculturing in medium with cefaclor did not affect the cefaclor MICs of three strains but and led to increased cefaclor MICs (from 0.5 to 2.0 to 4.0 µg/ml) for three of the six strains, with MICs of other beta -lactams rising 1 to 3 twofold dilutions. Subculturing in cefuroxime led to increased cefuroxime MICs (from 0.03 to 0.06 µg/ml to 0.125 to 0.5 µg/ml) for all six strains without significantly altering the MICs of other beta -lactams, except for one strain, which developed an increased cefaclor MIC. Subculturing in azithromycin did not affect beta -lactam MICs. Subculturing of the four strains with decreased penicillin susceptibility in amoxicillin (with or without clavulanate) or cefuroxime did not select for beta -lactam resistance. Subculturing of one strain in cefaclor led to an increase in MIC from 0.5 to 2.0 µg/ml after 19 passages. In contrast to strains that were initially azithromycin susceptible, which required >10 subcultures for resistance selection, three of four strains with azithromycin MICs of 0.125 to 4.0 µg/ml showed increased MICs after 7 to 13 passages, with the MICs increasing to 16 to 32 µg/ml. All azithromycin-resistant strains were clarithromycin resistant. With the exception of strains that contained mefE at the onset, no strains that developed resistance to azithromycin contained ermB or mefE, genes that have been found in macrolide-resistant pneumococci obtained from clinic patients.

* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, 500 University Dr., Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psghs.edu.

Antimicrobial Agents and Chemotherapy, November 1998, p. 2914-2918, Vol. 42, No. 11
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Hu, W. S., Lin, J.-F., Lin, Y.-H., Chang, H.-Y. (2009). Outer Membrane Protein STM3031 (Ail/OmpX-Like Protein) Plays a Key Role in the Ceftriaxone Resistance of Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother. 53: 3248-3255 [Abstract] [Full Text]  
  • Smith, K., Ednie, L. M., Appelbaum, P. C., Hawser, S., Lociuro, S. (2008). Antistreptococcal Activity of AR-709 Compared to That of Other Agents. Antimicrob. Agents Chemother. 52: 2279-2282 [Abstract] [Full Text]  
  • Clark, C., Smith, K., Ednie, L., Bogdanovich, T., Dewasse, B., McGhee, P., Appelbaum, P. C. (2008). In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci. Antimicrob. Agents Chemother. 52: 77-84 [Abstract] [Full Text]  
  • Hu, W. S., Yao, S.-M., Fung, C.-P., Hsieh, Y.-P., Liu, C.-P., Lin, J.-F. (2007). An OXA-66/OXA-51-Like Carbapenemase and Possibly an Efflux Pump Are Associated with Resistance to Imipenem in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51: 3844-3852 [Abstract] [Full Text]  
  • Kosowska-Shick, K., Credito, K. L., Pankuch, G. A., DeWasse, B., McGhee, P., Appelbaum, P. C. (2007). Multistep Resistance Selection and Postantibiotic-Effect Studies of the Antipneumococcal Activity of LBM415 Compared to Other Agents. Antimicrob. Agents Chemother. 51: 770-773 [Abstract] [Full Text]  
  • Kosowska, K., Hoellman, D. B., Lin, G., Clark, C., Credito, K., McGhee, P., Dewasse, B., Bozdogan, B., Shapiro, S., Appelbaum, P. C. (2005). Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin. Antimicrob. Agents Chemother. 49: 1932-1942 [Abstract] [Full Text]  
  • Matic, V., Kosowska, K., Bozdogan, B., Kelly, L. M., Smith, K., Ednie, L. M., Lin, G., Credito, K. L., Clark, C. L., McGhee, P., Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2004). Antipneumococcal Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Erythromycin, Azithromycin, Clarithromycin, Clindamycin, and Telithromycin. Antimicrob. Agents Chemother. 48: 4103-4112 [Abstract] [Full Text]  
  • Riska, P. F., Kutlin, A., Ajiboye, P., Cua, A., Roblin, P. M., Hammerschlag, M. R. (2004). Genetic and Culture-Based Approaches for Detecting Macrolide Resistance in Chlamydia pneumoniae. Antimicrob. Agents Chemother. 48: 3586-3590 [Abstract] [Full Text]  
  • Ready, D., Lancaster, H., Qureshi, F., Bedi, R., Mullany, P., Wilson, M. (2004). Effect of Amoxicillin Use on Oral Microbiota in Young Children. Antimicrob. Agents Chemother. 48: 2883-2887 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Ednie, L. M., Bozdogan, B., Katopodis, G. D., Beratis, N. G., Davies, T. A., Appelbaum, P. C. (2003). Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A). Antimicrob. Agents Chemother. 47: 2699-2702 [Abstract] [Full Text]  
  • Clark, C., Bozdogan, B., Peric, M., Dewasse, B., Jacobs, M. R., Appelbaum, P. C. (2002). In Vitro Selection of Resistance in Haemophilus influenzae by Amoxicillin-Clavulanate, Cefpodoxime, Cefprozil, Azithromycin, and Clarithromycin. Antimicrob. Agents Chemother. 46: 2956-2962 [Abstract] [Full Text]  
  • Clark, C. L., Nagai, K., Dewasse, B. E., Pankuch, G. A., Ednie, L. M., Jacobs, M. R., Appelbaum, P. C. (2002). Activity of cefditoren against respiratory pathogens. J Antimicrob Chemother 50: 33-41 [Abstract] [Full Text]  
  • Nagai, K., Davies, T. A., Jacobs, M. R., Appelbaum, P. C. (2002). Effects of Amino Acid Alterations in Penicillin-Binding Proteins (PBPs) 1a, 2b, and 2x on PBP Affinities of Penicillin, Ampicillin, Amoxicillin, Cefditoren, Cefuroxime, Cefprozil, and Cefaclor in 18 Clinical Isolates of Penicillin-Susceptible, -Intermediate, and -Resistant Pneumococci. Antimicrob. Agents Chemother. 46: 1273-1280 [Abstract] [Full Text]  
  • Kutlin, A., Roblin, P. M., Hammerschlag, M. R. (2002). Effect of Prolonged Treatment with Azithromycin, Clarithromycin, or Levofloxacin on Chlamydia pneumoniae in a Continuous-Infection Model. Antimicrob. Agents Chemother. 46: 409-412 [Abstract] [Full Text]  
  • Butler, T. (2001). Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics. J Antimicrob Chemother 48: 903-906 [Abstract] [Full Text]  
  • Nagai, K., Davies, T. A., Dewasse, B. E., Jacobs, M. R., Appelbaum, P. C. (2001). Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. J Antimicrob Chemother 48: 365-374 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Tait-Kamradt, A., Katopodis, G. D., Beratis, N. G., Sutcliffe, J., Appelbaum, P. C., Davies, T. A. (2001). Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob. Agents Chemother. 45: 342-344 [Abstract] [Full Text]  
  • Nagai, K., Davies, T. A., Dewasse, B. E., Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2000). In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae. J Antimicrob Chemother 46: 909-915 [Abstract] [Full Text]  
  • Nagai, K., Davies, T. A., Pankuch, G. A., Dewasse, B. E., Jacobs, M. R., Appelbaum, P. C. (2000). In Vitro Selection of Resistance to Clinafloxacin, Ciprofloxacin, and Trovafloxacin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 2740-2746 [Abstract] [Full Text]  
  • Tait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., Sutcliffe, J. (2000). Mutations in 23S rRNA and Ribosomal Protein L4 Account for Resistance in Pneumococcal Strains Selected In Vitro by Macrolide Passage. Antimicrob. Agents Chemother. 44: 2118-2125 [Abstract] [Full Text]  
  • Davies, T. A., Kelly, L. M., Jacobs, M. R., Appelbaum, P. C. (2000). Antipneumococcal Activity of Telithromycin by Agar Dilution, Microdilution, E Test, and Disk Diffusion Methodologies. J. Clin. Microbiol. 38: 1444-1448 [Abstract] [Full Text]  
  • Davies, T. A., Dewasse, B. E., Jacobs, M. R., Appelbaum, P. C. (2000). In Vitro Development of Resistance to Telithromycin (HMR 3647), Four Macrolides, Clindamycin, and Pristinamycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 414-417 [Abstract] [Full Text]  
  • Carsenti-Etesse, H., Roger, P.-M., Dunais, B., Durgeat, S., Mancini, G., Bensoussan, M., Dellamonica, P. (1999). Gradient plate method to induce Streptococcus pyogenes resistance. J Antimicrob Chemother 44: 439-443 [Abstract] [Full Text]  
  • Davies, T. A., Pankuch, G. A., Dewasse, B. E., Jacobs, M. R., Appelbaum, P. C. (1999). In Vitro Development of Resistance to Five Quinolones and Amoxicillin-Clavulanate in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 1177-1182 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»